Progression of targeted therapy in advanced cholangiocarcinoma
- This topic has 1 reply, 2 voices, and was last updated 8 years, 11 months ago by
.
Viewing 2 posts - 1 through 2 (of 2 total)
-
Posts
-
Very interesting. Recommend you read and discuss with your onc. Not everyone likes sorafenib (Mayo Clinic does, Cleveland Clinic and University Hospitals do not).
Duke
Progression of targeted therapy in advanced cholangiocarcinoma
http://www.thecjcr.org/article/view/6220/6963
Viewing 2 posts - 1 through 2 (of 2 total)
- The forum ‘New Developments’ is closed to new topics and replies.